SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who started this subject11/21/2000 10:39:36 AM
From: keokalani'nui  Read Replies (2) of 1784
 
Tuck, was MediChem considered for trickle watch list? Here is self description from recent s-1. MCLS.

Founded in 1987, we believe we were the first independent chemistry company to offer a broad array of discovery-related medicinal chemistry services to pharmaceutical and biotechnology customers. From a company focused exclusively on medicinal chemistry services, we have evolved into a full-service drug discovery technology and services company. Our development of strong relationships with pharmaceutical companies by initially providing basic medicinal chemistry services helped us to identify their unmet needs in the later stages of the drug discovery process. In response, we expanded our service offerings to include process development, analytical and separations chemistry and chemical synthesis and scale up. To capitalize on recent advances in genomics, we have developed technology and services in early-stage
proteomics, combinatorial chemistry and biocatalysis.

--Wilder
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News